People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Clinical trial NCT03520660 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03520660
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-19
- Primary completion
- 2032-12-31
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.